Adult stem cell specialist Mesoblast (ASX:MSB) has received ethics approval to commence its first human orthopaedic trial.

Mayne Pathology (ASX:MAY) has agreed to provide Sydney-based Medsaic's DotScan test for leukaemia and lymphoma in four states in Australia, with an official launch of the technology at Mayne Health Laverty Pathology in Sydney today.

BioTech Capital (ASX:BTC) investee company Continence Control Systems International (CCS) has commenced patient recruitment for its severe urinary incontinence treatment, following completion of pre-clinical studies and human ethics approval for human implants.

Two Melbourne researchers, Dr Merlin Thomas and Dr Stephen Ting, have jointly won the 2005 Victorian Premier's Award for Medical Research.

A Sydney company is hoping pathologists will be making room next to their flow cytometers for a new technology which provides doctors with a detailed profile of leukaemias and lymphomas, setting the scene for tailored treatment.

The US Patent and Trademark Office has granted Ventracor (ASX:VCR) and the company's research partners at the University of Technology Sydney a patent over the control system used in its VentrAssist heart device.

Cancer therapeutics company Australian Cancer Technology (ASX:ACU) announced today its GPI-0100 vaccine adjuvant has produced an enhanced immune response in its Phase I clinical trial in men with relapsed prostate cancer.

Meditech Research (ASX: MTR) has appointed former CSL and Millennium Pharmaceuticals executive Dr Ian Nisbet as CEO to replace Chris Carter who stepped down on Friday, after a shareholder stoush in April forced his resignation.

Prof Len Harrison, of the Walter and Eliza Hall Institute, has been awarded the David Rumbough award for scientific excellence by the Juvenile Diabetes Research Foundation International for his research towards finding a cure for type 1 diabetes.

Australia is home to a thriving and dynamic biotechnology industry with a firm footing in the world-class research base found in the universities and research institutions 'Down Under'.

Prof Len Harrison, of the Walter and Eliza Hall Institute, has been awarded the David Rumbough award for scientific excellence by the Juvenile Diabetes Research Foundation International for his research towards finding a cure for type 1 diabetes.